CORZQ — Core Scientific Cashflow Statement
0.000.00%
Last trade - 00:00
- $536.57m
- $1.36bn
- $640.31m
- 18
- 30
- 89
- 43
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -11.9 | -12.2 | 47.3 | -2,146 |
Depreciation | ||||
Non-Cash Items | -1.2 | 0.161 | -87.9 | 1,647 |
Unusual Items | ||||
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 6.17 | -21.1 | -49.5 | 479 |
Change in Accounts Receivable | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Other Liabilities | ||||
Net Change in Other Assets & Liabilities | ||||
Cash from Operating Activities | -0.832 | -23.8 | -56.7 | 205 |
Capital Expenditures | -37.5 | -15.2 | -424 | -602 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | 0.16 | 0.092 | 0.645 | 10.9 |
Sale of Business | ||||
Sale of Fixed Assets | ||||
Change in Net Intangibles | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -37.4 | -15.1 | -424 | -591 |
Financing Cash Flow Items | — | — | -10.7 | 163 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 28.7 | 40.7 | 604 | 306 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -9.5 | 1.81 | 123 | -79.4 |